Yun-Fei Ko,Jan Martel,Tsung-Ru Wu,Chih-Jung Chang,Chuan-Sheng Lin,Jian-Ching Liau,Wei-Chang Wang,Chen-Yaw Chiu,Chia-Chen Lu,David Marcelo Ojcius,Hsin-Chih Lai,John D. Young
申请号：
US15815134
公开号：
US10111915B1
申请日:
2017.11.16
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention describes a method to reduce blood aspartate transaminase level, liver weight, hepatic lipid accumulation and hepatocyte hypertrophy by administering the probiotic bacterium Parabacteroides goldsteinii to a subject showing signs of fatty liver disease. This probiotic bacterium can therefore be used to treat fatty liver disease.
